Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
— · Rhabdomyosarcoma, Melanoma · Completed · est. 2019-03-06
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Cardinal Health is lead sponsor; 1 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-01Current report (material event)
- ARS2026-09-21Annual report to holders
- DEFA14A2026-09-21DEFA14A
- DEF 14A2026-09-21Proxy statement
- SCHEDULE 13G2026-08-13SCHEDULE 13G
- 10-K2026-08-11Annual report
- 8-K2026-08-11Current report (material event)
- 8-K2026-08-11Current report (material event)
- 8-K2026-08-05Current report (material event)
- 11-K2026-06-2311-K
- 11-K2026-06-2311-K
- SD2026-06-01SD
- 10-Q2026-04-30Quarterly report
- 8-K2026-04-30Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- 8-K2026-03-23Current report (material event)
- 8-K2026-03-05Current report (material event)
- 10-Q2026-02-05Quarterly report
- 8-K2026-02-05Current report (material event)
- SCHEDULE 13G/A2026-01-21SCHEDULE 13G/A
- 8-K2026-01-13Current report (material event)
- 8-K2025-11-06Current report (material event)
- 10-Q2025-10-30Quarterly report
- 8-K2025-10-30Current report (material event)
- SCHEDULE 13G2025-10-17SCHEDULE 13G
- 8-K2025-10-10Current report (material event)
- 8-K2025-10-03Current report (material event)
- ARS2025-09-16Annual report to holders
- DEFA14A2025-09-16DEFA14A
- DEF 14A2025-09-16Proxy statement
- 8-K2025-08-27Current report (material event)
- 424B52025-08-15Prospectus (offering)
- 8-K2025-08-14Current report (material event)
- FWP2025-08-13FWP
- 424B32025-08-13424B3
- S-3ASR2025-08-12S-3ASR
- 10-K2025-08-12Annual report
- 8-K2025-08-12Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.